In addition, we use two peptide inhibitors with proven efficacy towards MMP-9 in an acute DSS-induced colitis model in three different set-ups: multiple dose prophylactic and therapeutic schemes, and continuous infusion via osmotic pumps. Here, MMP9 is linked to colitis.